New drugs for hepatic fibrosis

L Shan, F Wang, D Zhai, X Meng, J Liu… - Frontiers in …, 2022 - frontiersin.org
The morbidity and mortality of hepatic fibrosis caused by various etiologies are high
worldwide, and the trend is increasing annually. At present, there is no effective method to …

Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice

S Huang, Y Wang, S Xie, Y Lai, C Mo, T Zeng, S Kuang… - Phytomedicine, 2022 - Elsevier
Background Liver fibrosis is a major disease that threatens people's health around the
world. However, there is a lack of effective treatment to completely reverse liver fibrosis …

Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis

F Bu, P Jia, Y Zhu, Y Yang, H Meng, Y Bi… - … Therapy-Methods & …, 2022 - cell.com
Liver fibrosis is a wound-healing response that results from various chronic damages. If the
causes of damage are not removed or effective treatments are not given in a timely manner …

Effective delivery of osteopontin small interference RNA using exosomes suppresses liver fibrosis via TGF-β1 signaling

M Tang, C Guo, M Sun, H Zhou, X Peng… - Frontiers in …, 2022 - frontiersin.org
Objective and aims: Osteopontin (OPN), an oxidant stress sensitive cytokine, plays a central
role in liver fibrosis. While OPN expression can be reduced by small interfering RNA …

Curcumin and berberine co-loaded liposomes for anti-hepatocellular carcinoma therapy by blocking the cross-talk between hepatic stellate cells and tumor cells

J Wu, C Qi, H Wang, Q Wang, J Sun, J Dong… - Frontiers in …, 2022 - frontiersin.org
Cancer-associated fibroblasts (CAFs) are a major component of the tumor microenvironment
(TME). In hepatocellular carcinoma (HCC), quiescent hepatic stellate cells (HSCs) could be …

ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner

JJ Yang, J Wang, Y Yang, Y Yang, J Li, D Lu… - European journal of …, 2022 - Elsevier
Abstract N6-methyladenosine (m 6 A) is the reversible epigenetic modification of mRNA
biogenesis. However, its potential role in HSCs activation and liver fibrosis remains poorly …

Nestin-dependent mitochondria-ER contacts define stem Leydig cell differentiation to attenuate male reproductive ageing

S Yao, X Wei, W Deng, B Wang, J Cai, Y Huang… - Nature …, 2022 - nature.com
Male reproductive system ageing is closely associated with deficiency in testosterone
production due to loss of functional Leydig cells, which are differentiated from stem Leydig …

Transient Receptor Potential Vanilloid‐1 (TRPV1) Alleviates Hepatic Fibrosis via TGF‐β Signaling

K Qian, X Lei, G Liu, Y Fang, C Xie, X Wu… - Disease …, 2022 - Wiley Online Library
Hepatic fibrosis is a major global health problem and considered a leading cause of liver‐
related morbidity and mortality worldwide. Although previous studies have suggested that …

Hepatoprotective efficacy and interventional mechanism of Qijia rougan decoction in liver fibrosis

XF Chen, Y Wang, S Ji, X Sun, Q Feng, H Yu… - Frontiers in …, 2022 - frontiersin.org
Liver fibrosis is a leading contributor to chronic liver diseases such as cirrhosis and liver
cancer, which pose a serious health threat worldwide, and there are no effective drugs to …

Vitamin B6 metabolic pathway is involved in the pathogenesis of liver diseases via multi-omics analysis

M Mei, D Liu, X Tang, Y You, B Peng… - Journal of …, 2022 - Taylor & Francis
Purpose To clarify the underlying regulatory mechanisms of progression from liver cirrhosis
to hepatocellular carcinoma (HCC), we analyzed the microbiomics, metabolomics, and …